Skip to main content

Research Repository

Advanced Search

All Outputs (3)

Perovskite nanoparticles as contrast agents for molecular imaging and anti-cancer theranostics (2019)
Thesis
AL Habsi, S. K. S. (2019). Perovskite nanoparticles as contrast agents for molecular imaging and anti-cancer theranostics. (Thesis). University of Hull. Retrieved from https://hull-repository.worktribe.com/output/4223738

Nanoparticles (NPs) offer diagnostic and therapeutic capabilities not accessible with microscale particles. As the field of molecular imaging has risen up out of the mixing of molecular biology with medicinal imaging, the use of NPs as imaging contra... Read More about Perovskite nanoparticles as contrast agents for molecular imaging and anti-cancer theranostics.

Theranostic porphyrin conjugates for the combined treatment and diagnosis of cancer (2019)
Thesis
Yap, S. Y. (2019). Theranostic porphyrin conjugates for the combined treatment and diagnosis of cancer. (Thesis). University of Hull. Retrieved from https://hull-repository.worktribe.com/output/4221753

The development of theranostic agents capable of the combined treatment of diagnosis of disease has seen a growing interest within the research community. The combination of diagnostic and treatment modality onto a single construct will allow the car... Read More about Theranostic porphyrin conjugates for the combined treatment and diagnosis of cancer.

The development of a multimodal imaging agent for the management of diabetes mellitus type 2 (2019)
Thesis
Garrod, A. J. (2019). The development of a multimodal imaging agent for the management of diabetes mellitus type 2. (Thesis). University of Hull. Retrieved from https://hull-repository.worktribe.com/output/4221898

Diabetes Mellitus is a metabolic disorder with multiple aetiologies with an estimated 422 million people with the condition, which is characterised by the chronic presence of hyperglycaemia and dysfunction in carbohydrate, protein, and fat metabolism... Read More about The development of a multimodal imaging agent for the management of diabetes mellitus type 2.